| Oct 28, 2009
| 4:32 PM
About this time last year, we were reporting on the failure of several investigational weight-loss medications. They included Sanofi-Aventis' rimonabant as well as two other drugs that aimed to work by blocking cannabinoid receptors in the brain. However, one
| Dec 20, 2013
| 2:38 AM
Dec 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Accenture and Coca-Cola, on Friday.
* Accenture : Jefferies, BMO raises price target on the stock
| Dec 19, 2013
| 1:03 PM
Dec 19 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 2100 GMT on Thursday:
** Belgian financial group KBC said it would sell Antwerp
Diamond Bank to a Chinese investor, the final unit it agreed to
sell for approval...
| Nov 21, 2013
| 1:30 PM
Nov 21 (Reuters) - VIVUS Inc :
* On November 18, 2013, co entered into a manufacturing and
with Sanofi winthrop, a unit of Sanofi
* Says Sanofi winthrop will manufacture and supply tablets for
avanafil on an exclusive...
| May 5, 2010
| 10:57 PM
LOS ANGELES -- It's a condition called 'Female Sexual Dysfunction," or 'FSD,' supposedly afflicting women who are dissatisfied with their sex lives. It's been widely reported to affect 43 percent of all women -- but it is real?